ArticleOncotarget2015

ASXL1 mutation correction by CRISPR/Cas9 restores gene function in leukemia cells and increases survival in mouse xenografts.

Simona Valletta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.